$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County
Young people with disabilities focus of COVID-19 testing grant (Links to an external site)
Category: Research
Fluvoxamine may prevent serious illness in COVID-19 patients (Links to an external site)
Antidepressant drug repurposed for patients with coronavirus infection
Uncovering genetic roots of marijuana use disorder (Links to an external site)
As more states enact laws legalizing pot, addiction problems may increase
College students access eating disorders therapy via phone app (Links to an external site)
Multi-university study shows app can help students reduce symptoms, ease depression
African American children with autism experience long delays in diagnosis (Links to an external site)
Such delays lead to serious disparities in access to developmental therapy
Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide (Links to an external site)
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
$13.7 million to further adolescent brain development study (Links to an external site)
Grant from National Institute on Drug Abuse to extend landmark study
Potential biomarker for autism identified in infants (Links to an external site)
Low levels of neuropeptide in babies’ cerebrospinal fluid linked to later diagnosis.
WashU to test OCD drug for potential COVID-19 treatment (Links to an external site)
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Can a long-used antidepressant stop COVID-19’s deadly ‘cytokine storm’? (Links to an external site)
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.